Latest Breaking News On - Pharmarack technologies - Page 1 : comparemela.com

Share Market Highlights 20 July 2023: Sensex jumps 470 pts, ends above 67,500; Nifty nears 20,000; ITC among top gainers

Share Market Highlights 20 July 2023: Sensex jumps 470 pts, ends above 67,500; Nifty nears 20,000; ITC among top gainers
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshUttar pradeshIndia generalNew yorkUnited statesHimachal pradeshTamil naduMadhya pradeshRashid ahmed mirzaAlok industrieMotilal oswalBajaj hindusthanLarsen toubroHitesh kumar sethiaBajaj finservVinod sureka

Experts to deliberate on key issues at BioAsia 2023

The delegates will witness several panel discussions around compelling global health topics during the event, which is scheduled to happen in Hyderabad on February 24-26, 2023

Andhra pradeshUnited statesUnited kingdomWorld trade centerTamil naduUniversity of illinoisHaris bhartiaEkta batraShyam bishenJayesh ranjanPavan kumar mocherlaShereen bhanRama raoAnnaswamy vaidheeshSuresh pattathilPrem pavoor

Sun Pharma acquires stake in Pharmarack Technologies

Sun Pharma acquires stake in Pharmarack Technologies
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Sun pharmaceutical industriesIndohealth servicesDigihealth technologiesPharmarack technologiesCapital marketசூரியன் மருந்து தொழில்கள்மூலதனம் சந்தை

Sun Pharma announces acquisition of ownership interest in Pharmarack Technologies

Sun Pharmaceutical Industries announced that DigiHealth Technologies LLP, the wholly owned entity of its Indian wholly owned subsidiary s investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), has agreed to acquire 100% ownership interest in Pharmarack Technologies in tranches. The upfront acquisition of 91.8% of shareholding in Pharmarack is expected to be completed within a period of 30 (thirty) days by purchase of shares from multiple existing shareholders in various lots. The remaining 8.2% of the shareholding in Pharmarack is likely to be acquired in multiple tranches over the next 5 (five) years. Cost of acquisition to DigiHealth Technologies LLP for upfront acquisition of 91.8% is Rs 111 crore.

Sun pharmaceutical industriesIndohealth servicesDigihealth technologiesPharmarack technologiesCapital marketBse sensexNifty 50Limited liability partnershipSun pharmaLegal fictionsGeneric pharmaceuticalsInvestment holding companies necSoftware necPharmaceuticals necசூரியன் மருந்து தொழில்கள்மூலதனம் சந்தை